Drug Profile
Research programme: peptide-carrier therapeutics - PYC Therapeutics /Roche
Alternative Names: Cell-penetrating peptides - Phylogica/Roche; Phylomer® carrier peptides - Phylogica/RocheLatest Information Update: 15 Sep 2023
Price :
$50
*
At a glance
- Originator Phylogica; Roche
- Developer PYC Therapeutics; Roche
- Class Drug conjugates; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders; Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Neurological-disorders in Australia
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in Australia
- 23 May 2011 Early research in Neurological disorders in Australia (unspecified route)